CNS Clinical Trials

Suicidality and Data Collection: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy

Häftad, Engelska, 2010

420 kr

Skickas . Fri frakt över 249 kr.

Beskrivning

The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.

Produktinformation

Utforska kategorier

Innehållsförteckning

Hoppa över listan

Mer från samma författare

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad, 1984

1 999 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad, 1986

1 929 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad, 1991

1 257 kr

Risk Communication and Vaccination

Institute of Medicine, Board on Health Promotion and Disease Prevention, Michael A. Stoto, Barbara Loe Fisher, Richard B. Johnston, Ann Bostrom, Geoffrey Evans

Häftad, 1997

1 328 kr

Hoppa över listan

Du kanske också är intresserad av

Neuroscience Biomarkers and Biosignatures

Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce Altevogt, Sarah Hanson, Miriam Davis

Häftad, 2008

621 kr

Neurodegeneration

Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Miriam Davis

Häftad, 2013

397 kr